BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32582375)

  • 1. Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries.
    Del Pilar Estevez-Diz M; Bonadio RC; Miranda VC; Carvalho JP
    Ecancermedicalscience; 2020; 14():1060. PubMed ID: 32582375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospitals' responsibility in response to the threat of infectious disease outbreak in the context of the coronavirus disease 2019 (COVID-19) pandemic: Implications for low- and middle-income countries.
    Zhang J; Lu X; Jin Y; Zheng ZJ
    Glob Health J; 2020 Dec; 4(4):113-117. PubMed ID: 33294250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and difficulties faced in low- and middle-income countries during COVID-19.
    Moyazzem Hossain M; Abdulla F; Rahman A
    Health Policy Open; 2022 Dec; 3():100082. PubMed ID: 36405972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Novel Coronavirus (COVID-19) Pandemic and the Response in Low-to-Middle Income Countries.
    Shahzad H; Mubarik F; Sattar AK
    Curr Breast Cancer Rep; 2021; 13(2):63-68. PubMed ID: 33880139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Cancer Management in COVID-19 Pandemic.
    Ömeroğlu Şimşek G
    Turk Thorac J; 2020 Sep; 21(5):340-344. PubMed ID: 33031726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingency planning for cancer care in low- and middle-income countries during the COVID-19 pandemic: a rapid assessment for future disaster resilience.
    Teoh SP; Hoo YY; Murillo R; Zuluaga M; Tsunoda A; Lombe D; Sullivan R; Bhoo-Pathy N
    Ecancermedicalscience; 2022; 16():1339. PubMed ID: 35242220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of cancer patients during COVID-19 pandemic at developing countries.
    González-Montero J; Valenzuela G; Ahumada M; Barajas O; Villanueva L
    World J Clin Cases; 2020 Aug; 8(16):3390-3404. PubMed ID: 32913846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of COVID-19 in oncohematological patients.
    Alcaraz R; Saiz-Rodríguez M; Cuevas B; González-López TJ; Labrador J
    Am J Blood Res; 2020; 10(3):52-53. PubMed ID: 32685259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.
    de Marinis F; Attili I; Morganti S; Stati V; Spitaleri G; Gianoncelli L; Del Signore E; Catania C; Rampinelli C; Omodeo Salè E; Spaggiari L; Mastrilli F; Passaro A
    Front Oncol; 2020; 10():665. PubMed ID: 32391282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and its ramifications for cancer patients in low-resource settings: Ghana as a case study.
    Kugbey N; Ohene-Oti N; Vanderpuye V
    Ecancermedicalscience; 2020; 14():ed99. PubMed ID: 32346393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth.
    Kamposioras K; Mauri D; Papadimitriou K; Anthoney A; Hindi N; Petricevic B; Dambrosio M; Valachis A; Kountourakis P; Kopecky J; Kuhar CG; Popovic L; Chilingirova NP; Zarkavelis G; de Mello RA; Plavetić ND; Christopoulos C; Mostert B; Goffin JR; Tzachanis D; Saraireh HH; Ma F; Pavese I; Tolia M
    Front Oncol; 2020; 10():575148. PubMed ID: 33330049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The recovery strategies to support cervical cancer elimination in lower-and middle-income countries (LMICs) following COVID-19 disruptions.
    Lee J; Ismail-Pratt I; Machalek DA; Kumarasamy S; Garland SM
    Prev Med Rep; 2023 Oct; 35():102291. PubMed ID: 37455756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the Management of Malignant Bone Tumors in the COVID-19 Pandemic in Developing Countries.
    Tiwari V; Sharma PK; Sampath Kumar V; Poudel RR; Meena S; Banjara R
    Cureus; 2022 May; 14(5):e25245. PubMed ID: 35755501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation oncology practice during COVID-19 pandemic in developing countries.
    Abuhijla F; Abuhijlih R; Mohamad I
    World J Clin Cases; 2021 Sep; 9(25):7292-7296. PubMed ID: 34616794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritization of Proton Patients in the COVID-19 Pandemic: Recommendations from The New York Proton Center.
    Chhabra AM; Choi JI; Hasan S; Press RH; Simone CB
    Int J Part Ther; 2020; 6(4):38-44. PubMed ID: 32582818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home-deliverable antitumoral treatments in the age of COVID-19: the Portsmouth experience and a narrative review.
    Mechahougui H; Yusof H; Baudoux N; Acharige S; Friedlaender A
    Mediastinum; 2022; 6():12. PubMed ID: 35832238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 pandemic on breast and cervical cancer stage at diagnosis in Brazil.
    Bonadio RC; Messias AP; Moreira OA; Leis LV; Orsi BZ; Testa L; Estevez-Diz MDP
    Ecancermedicalscience; 2021; 15():1299. PubMed ID: 34824622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creating Backup Management Resources for Spine Care during the Coronavirus Disease 2019 Pandemic.
    Yadav SK; Kar BK; Banta A; Kumar A
    Asian Spine J; 2020 Jun; 14(3):382-384. PubMed ID: 32403895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should cancer treatment be continued during the COVID-19 pandemic? A single Egyptian institution experience.
    Elkhouly EA; Salem RH; Haggag M
    Ecancermedicalscience; 2020; 14():1077. PubMed ID: 32863871
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.